What benefit might there be in very low nicotine combustible cigarettes? That is the essential question the US FDA must answer in assessing a modified risk tobacco product (MRTP) application from 22nd Century Group for its VLN products
Submit your access request to explore how it streamlines access to critical market and regulatory insights
"*" indicates required fields